Trial Profile
Efficacy and safety of sofosbuvir in combination with daclatasvir in patients with Hepatitis C virus associated cryoglobulinemia vasculitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2017
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 14 Jan 2017 New trial record